Cases

OPINION BY FORD ELLIOTT, P.J.E.: Timothy Stange ("Stange"), plaintiff in the court below, and defendants, Janssen Pharmaceuticals, Inc. ("Janssen"), Johnson & Johnson, and Janssen Research & Development, LLC, 1 have taken cross-appeals from the judgment entered in favor of Stange in the amount of $535,106.17. Stange,

Case: 22-1258 Document: 70 Page: 1 Filed: 04/01/2024 United States Court of Appeals for the Federal Circuit ______________________ JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV, Plaintiffs-Appellees v. TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LTD., Defendants-Appellants ______________________ 2022-1258, 2022-1307

STARK, U.S District Judge MorphoSys, Inc. ("MorphoSys" or "Plaintiff") sued Janssen Biotech, Inc., Genmab US, Inc., and Genmab A/S (together, "Janssen" or "Defendants") for infringement of three patents on antibodies that bind to the CD38 protein. (D.I. 205) Pending before the Court are summary judgment motions filed by both sides. Janssen moves for summary judgment of (1) non-infringement of the "human" antibody claims (D.I. 384) a

The Supreme Court of South Carolina State of South Carolina ex rel. Alan Wilson, in his capacity as Attorney General of the State of South Carolina, Respondent, v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutical, Inc., and/or Janssen, L.P., and Johnson & Johnson, Inc., Defendants, of whom Ortho-McNeil-Janssen Pharmaceuticals, Inc. is

OPINION WALLS, Senior District Judge. By complaints, Plaintiff patent-holders and drug-makers have sued Defendant generic drug manufacturers for alleged infringements of patents on a chemical compound used in the manufacture of Plaintiff’s product, Prezista. The patents, for this opinion, are U.S. Patent No. 7,700,645 B2 (the “'645 Patent”), U.S. Patent No. 7, 126,015 B2 (the “'015 Patent”), and U.S. Pate

Wallach, Circuit Judge. *1066 Appellants BTG International Limited et al. ("Appellants") sued Appellees Amneal Pharmaceuticals LLC et al. ("Appellees") in the U.S. District Court for the District of New Jersey ("District Court"), asserting that Appellees' Abbreviated New Drug Applicatio

540 F.3d 1353 (2008) JANSSEN PHARMACEUTICA, N.V. and Janssen, L.P., Plaintiffs-Appellees, v. APOTEX, INC., Defendant-Appellant. No. 2008-1062. United States Court of Appeals, Federal Circuit. September 4, 2008. *1355 Scott B. Howard, Patterson Belknap Webb & Tyler LLP, of New York, NY, argued for plaintiffs-appellees. With hi

THE STATE OF SOUTH CAROLINA In The Supreme Court State of South Carolina ex. rel. Alan Wilson, in his capacity as Attorney General of the State of South Carolina, Respondent, v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutical, Inc., and/or Janssen, L.P., and Johnson & Johnson, Inc., Defendants, of whom Ortho-McNeil-Janssen Pharmaceuticals, Inc. is the Appellant. Appellate Case No. 2012-206987 Appeal from Spartanburg County

United States Court of Appeals for the Federal Circuit ______________________ ABBVIE DEUTSCHLAND GMBH & CO., KG, ABBVIE BIORESEARCH CENTER, INC., AND ABBVIE BIOTECHNOLOGY, LTD., Plaintiffs-Appellants, v. JANSSEN BIOTECH, INC. AND CENTOCOR BIOLOGICS, LLC, Defendants-Appellees. ----------------------- JANSSEN BIOTECH, INC., Plaintiff–A

790 F.Supp.2d 868 (2011) ALCON RESEARCH, LTD. (f/k/a Alcon Manufacturing, Ltd.), Alcon Laboratories, Inc., and Kyowa Hakko Kirin Co., Ltd., Plaintiffs, v. APOTEX INC. and Apotex Corp., Defendants. No. 1:06-cv-1642-RLY-TAB. United States District Court, S.D. Indiana, Indianapolis Division. May 23, 2011. *872 Adam L. Perlman, Bruce

784 F.Supp.2d 508 (2011) DISTRICT 1199P HEALTH AND WELFARE PLAN, et al., Plaintiffs, v. JANSSEN, L.P., et al., Defendants. Civil Action No. 10-2021 (FLW). United States District Court, D. New Jersey. March 21, 2011. *512 Brian J. McCormick, Jr., Sheller, PC, Philadelphia, PA, Rosalee B. Connell, Finkelstein Thompson LLP, Washingt

STEPHEN L. CROCKER, Magistrate Judge *837This lawsuit presents a land contract dispute that arises out of a failed frac sand mining venture. Jurisdiction is present under 28 U.S.C. § 1332. See Jan. 13, 2017 Ord., dkt. 41 (denying motion to dis

Lourie, Circuit Judge. Plaintiffs-Appellants (collectively, "Sanofi") appeal from the judgment of the U.S. District Court for the District of New Jersey holding, after a bench trial, claims 7, 11, 14-16, and 26 of U.S. Patent 8,927,592 (the " '592 patent") invalid as obvious. Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC , No. 14-7869 (D.N.J. Dec. 19, 2017) ("

[Regarding Application of the Court's Prior Rulings on Manifestation, Incidental Damages (Lost Time), and Unjust Enrichment to All Remaining Jurisdictions in Dispute (MDL Order No. 131 Issues) ] JESSE M. FURMAN, United States District Judge INTRODUCTION... 274 LEGAL STANDARDS... 275 DISCUSSION... 275 A. Manifestation... 276

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE TRIFECTA MULTIMEDIA HOLDINGS ) INC., and DAVE YOUNG, ) ) Plaintiffs, ) ) v. ) C.A. No. 2023-0699-JTL ) WCG CLINICAL SERVICES LLC, )

609 F.Supp.2d 1282 (2009) EXHIBIT ICONS, LLC et al, Plaintiffs, v. XP COMPANIES, LLC, et al, Defendants. No. 07-80824-CIV. United States District Court, S.D. Florida. March 26, 2009. *1287 Mark Robert Vogel, Mark R. Vogel, P.A., Hollywood, FL, Steven Frederick Samilow, Weston, FL, for Plaintiffs. Steven Neil Lippman, Roths

PROST, Chief Judge. Appellants Sanofi, Aventisub LLC, Re-generan Pharmaceuticals Inc., and Sanofi-Aventis U.S., LLC (collectively, “Appellants”) appeal from a final judgment of the district court holding U.S. Patent Nos. 8,829,165 (“’165 patent”) and 8,859,741 (“’741 patent”) not invalid and granting a permanent injunction enjoining sales of Appellants’

COURT OF APPEALS EIGHTH DISTRICT OF TEXAS EL PASO, TEXAS § WHATABURGER RESTAURANTS No. 08-13-00280-CV LLC, § Appeal from Appellant, §

ORDER CINDY K. JORGENSON, District Judge. Plaintiffs Joshua David Mellberg, LLC, dba J.D. Mellberg Financial, and Joshua David Mellberg filed a First Amended Complaint asserting 11 counts against various Defendants. (Doc. 9, FAC) Four motions are now pending before the Court: (1) Partial Motion to Dismiss filed by Defendants Jovan Will and Tree Fine (Doc. 22); (2) Motion to Dismiss filed by Defendant the Imp

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA UNITED STATES OF AMERICA v. Criminal Action No. 18-cr-0032-2 (DLF) CONCORD MANAGEMENT & CONSULTING LLC, Defendant. MEMORANDUM OPINION* Concord Management and Consulting LLC moves to dismiss the indictment on the ground that Special Counsel Robert Mueller was app